81 results
S-3
SILO
SILO Pharma Inc
23 Jan 24
Shelf registration
5:01pm
candidates will depend on the degree of market access and acceptance of our potential therapies among healthcare professionals, patients, healthcare … statement, over the internet at the SEC’s website at http://www.sec.gov. We also maintain a website at www.silopharma.com, at which you may access
8-K12B
EX-3.4
SILO
SILO Pharma Inc
20 Dec 23
Notification of registration of securities
4:58pm
the meeting is to be held or (B) on a reasonably accessible electronic network, provided that the information required to gain access to such list … during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided
8-K
SILO
SILO Pharma Inc
5 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
from our website at https://ir.silopharma.com/sec-filings/.. Stockholders can also access the Proxy statement at the Company’s transfer agent’s proxy
8-K
EX-99.1
lmzse0o4u uw7
1 Dec 22
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
4:16pm
8-K
EX-10.2
dn8oeoje3p59tfu20uos
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
8kkb8rnfa adubym
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
EX-4.1
5dbeynl f3d
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
EX-1.1
469rx
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
424B4
npviiao2
28 Sep 22
Prospectus supplement with pricing info
4:34pm